Furthermore, survivin was expressed at higher levels in glioma stem cells than in their non-stem cell counterparts as previously reported [35], and the RG7112-induced reduction in survivin expression was more pronounced in the former than in the latter (Figure 5B). Here, BIRC5 is linked to central nervous system cancer.